Analyst Price Target is $0.78
▲ +421.53% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for MediPharm Labs in the last 3 months. The average price target is $0.78, with a high forecast of $0.80 and a low forecast of $0.75. The average price target represents a 421.53% upside from the last price of $0.15.
Current Consensus is
The current consensus among 3 investment analysts is to hold stock in MediPharm Labs. This Hold consensus rating has held steady for over two years.
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company focuses on the downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. It supplies raw materials, formulations, processing, and packaging for the creation of ready-to-sell derivative products. The company was founded by Patrick McCutcheon in 2015 and is headquartered in Barrie, Canada.